About 22 results
Our mission at APIE Therapeutics is to improve healthcare outcomes for patients suffering from debilitating and often fatal diseases in pulmonary, cardiovascular, renal and metabolic organs by using an approach rooted in science by a team with a proven record of technical expertise, dedication and courage.To improve healthcare outcomes fo...
Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder. We are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare ...
GeneOne Life Science, Inc. is a biopharmaceutical R&D company dedicated to the development and contract manufacturing of Gene-based-Biomedicines, including DNA vaccines. GeneOne Life Science is a global leader in the field of gene-based biomedicine. Between 2014 and 2016, GeneOne Life Science advanced three DNA vaccines into clinical tria...
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus’. The issued patents&rsquo...
Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychia...
MAX BioPharma is a privately-held preclinical stage California-based biopharmaceutical company developing novel small molecule lipids as drug candidates for intervention in debilitating and fatal human diseases. The company will be a leader in a new field of Oxysterol Therapeutics® by leveraging a robust and growing intellectual prope...
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical needs. The Company’s focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition. Modus' largest owners are Karolinska Development (Nasdaq Stockholm: KDEV), KDev Investments AB, (joint...
NeRRe Therapeutics is a clinical-stage company developing the neurokinin(NK)-1 receptor antagonist orvepitant for the treatment of common, chronic, and debilitating conditions caused by neural hypersensitivity associated with Substance P/ NK-1 receptor system dysfunction.Our focus with orvepitant is on the disabling chronic cough associat...
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) is an emerging global biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat rare, debilitating and often fatal diseases. Raptor’s first product, PROCYSBI® (cysteamine bitartrate) delayed-release capsules, received FDA approval in Apri...
Rasna Therapeutics was formed in 2013 by a highly experienced industry team together with field-leading scientists, to focus on developing therapeutics to address the high unmet need that exists for AML and other forms of leukemia. Our primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5...
Complete the form on this page and let us know what you're looking for (API, Finished Drug Products, Excipients, Contract Services (CMO, CRO, CDMO etc.).
The more detailed your request, the quicker we can shortlist companies which will meet your requirements.
Our team will reach out to you over email or phone to better understand your needs.
We select the partner companies matching your requirements from our database (more than 5,000 companies) & also call the right contact within the supplier organization.
Once the companies have confirmed that they can meet your needs and are interested in the opportunity, we connect you directly with the right contact by email.
There are no commissions or other conditions attached.
